Former Executive Vice President and President, Human Health · Merck & Co., Inc. (MRK)

Frank Clyburn

FY2021 is the first fiscal year CompBrief holds for Frank Clyburn as a named executive officer of Merck; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$9,921,071

Salary $960,343Stock awards $5,956,031

3rd of 6 named executive officers at Merck by FY2021 total.

6 named officers on file for Merck, FY2021

Frank Clyburn’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • MRK’s disclosed peer group of 12 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Merck’s whole pay program stands against its peers

  • Merck’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MRK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 4, 2022 (DEF 14A).

Free

Get Frank Clyburn’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Frank Clyburn compensation by year

Merck Summary Compensation Table · the one fiscal year held
In US dollars, as Merck reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$960,343
Bonus$0
Stock awards$5,956,031
Option awards$1,290,003
Non-equity incentive$1,443,506
Pension and deferred compensation$187,604
All other$83,584
Total$9,921,071

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Merck & Co., Inc. DEF 14A filed April 4, 2022, accession 0001193125-22-095134, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Merck & Co., Inc. filed document, accession 0001193125-22-095134. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2022.

Merck’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Kenneth FrazierExecutive Chairman and Former Chief Executive Officer$15,196,920
Robert DavisChief Executive Officer, President and Former Chief Financial Officer$13,722,121
Frank Clyburn · this pageFormer Executive Vice President and President, Human Health$9,921,071
Richard DeLucaExecutive Vice President and President, Merck Animal Health$6,841,000
Dean LiExecutive Vice President and President, Merck Research Laboratories$5,480,919
Caroline LitchfieldExecutive Vice President and Chief Financial Officer$4,221,454

The full Merck compensation record

free company brief

This page is one person within Merck's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Merck proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Merck's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Frank Clyburn's compensation dossier · One-time report. No refunds.